Allegra Medical Technologies Ltd (ASX: AMT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Allegra Medical Technologies Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$3.47 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
119.61 million
Earnings per share
-0.025
Dividend per share
N/A
Year To Date Return
-35.56%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Allegra Medical Technologies Ltd (ASX: AMT)
Latest News
Share Market News
Allegra (ASX:AMT) share price lifts 6% after reporting loss
Share Market News
Why the Allegra (ASX:AMT) share price is rocketing 20% higher today
AMT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Allegra Medical Technologies Ltd
Allegra Orthopaedics Ltd. engages in the designing, prototyping and manufacturing of medical devices and surgical implants. It offers orthopaedic, spinal products, medical devices and consulting services. The company was founded by Gregory James Roger in September 1994 and is headquartered in Lane Cove West, Australia.
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 09 Nov 2023 | Peter Kazacos | Expiry | 82,452 | $2,968 |
Options expired.
|
| 09 Nov 2023 | Sean Mulhearn | Expiry | 82,452 | $2,968 |
Options expired.
|
| 04 Sep 2023 | Nicholas Hartnell | Issued | 12,758,316 | $1,148,248 |
Rights issue.
|
| 04 Sep 2023 | Peter Kazacos | Issued | 46,148 | $4,153 |
Rights issue.
|
| 04 Sep 2023 | Sean Mulhearn | Issued | 111,111 | $9,999 |
Rights issue.
|
| 04 Sep 2023 | Sean Mulhearn | Transfer | 333,333 | $20,333 |
Off-market transfer. Assuming off-market transfer of shares
|
| 04 Sep 2023 | Sean Mulhearn | Issued | 111,111 | $9,999 |
Rights issue.
|
| 04 Sep 2023 | Sean Mulhearn | Transfer | 333,333 | $20,333 |
Off-market transfer. Assuming off-market transfer of shares
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Peter Kazacos | Non-Executive DirectorNon-Executive Chairman | May 2006 |
Mr Kazacos has over 40 years of experience in the IT industry. He founded KAZ in 1988, guided it from a small IT services company in NSW to one of Asia Pacific's IT services and business process outsourcing service providers with over 4,000 employees, as a fully owned subsidiary of Telstra. He also founded Anittel Ltd, building it into one of Australia's IT&C service providers operating outside the metropolitan areas, leading to its acquisition in 2010 by Anittel Group Limited (since renamed Axxis Technology Group Ltd.), representing a strategic milestone in the transformation and convergence of the IT&T industry. He is member of the Risk Committee.
|
| Mr Sean St Clair Mulhearn | Non-Executive Director | Nov 2015 |
Mr Mulhearn has been involved in the financial markets for over 30 years with experience in Asia, Europe and the Americas. Sean has expertise in risk management. He founded Jacaranda Capital Partners, a boutique advisory and markets training business with offices in Singapore and Australia. He is Chair of Risk Committee.
|
| Dr Nicholas Hartnell | Non-Executive Director | Mar 2018 |
Dr Hartnell as an orthopaedic surgeon brings to the Company orthopaedic industry experience. Since then, he has been focused on orthopaedic training and specialization and hence has many years of experience in all facets of Orthopaedic care. Nicholas set up his practice in Bowral in the Southern Highlands, NSW and has since expanded his surgical practice into the Goulburn, and Camden/Campbelltown areas. He is member of the Risk Committee.
|
| Ms Jenny Swain | Chief Executive Officer | May 2016 |
-
|
| Ms Robyn Slaughter | Company Secretary | Feb 2022 |
-
|
| Jenny Swain | Chief Executive Officer |
-
|
|
| Robyn Slaughter | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Robinwood Investments Pty Ltd | 38,274,948 | 36.64% |
| Netwealth Investments Limited (Wrap Services A/C) | 9,447,356 | 9.04% |
| Welsh Superannuation Pty Limited | 6,600,000 | 6.32% |
| Marie Caroll & Dawson Caroll | 5,636,285 | 5.40% |
| Bnp Paribas Nominees Pty Ltd Acf Clearstream | 4,958,074 | 4.75% |
| The University Of Sydney | 4,806,000 | 4.60% |
| Dr Andrew William Leicester & Mrs Skye Christine Leicester (Leicester Super Fund A/C) | 3,353,123 | 3.21% |
| 4 Holes In One Pty Ltd (Number 5 A/C) | 3,000,000 | 2.87% |
| Dugal Diagnostics Pty Ltd (The Dugal Family A/C) | 3,000,000 | 2.87% |
| Dr Andrew William Leicester & Mrs Skye Christine Leicester | 2,272,270 | 2.18% |
| Chew Investments Pty Ltd (Chew Investments A/C) | 1,333,333 | 1.28% |
| Mr Nicholas Hartnell | 1,224,090 | 1.17% |
| Mr Richard Ulrick & Mrs Wendy Ulrick (Ulrick Super Fund A/C) | 1,038,318 | 0.99% |
| Mergin Investments Pty Ltd (M & V Cross Super Fund A/C) | 1,000,000 | 0.96% |
| Mr Kenneth Campbell | 1,000,000 | 0.96% |
| Mr Thomas James Carroll | 1,000,000 | 0.96% |
| Destin Pty Limited | 946,470 | 0.91% |
| Misty Hills Nominees Pty Ltd | 892,857 | 0.85% |
| Mr Fenton Paul Healy (Cheeky Monkey A/C) | 545,000 | 0.52% |
| Desmond J Bokor Pty Limited (Kooringa Super Fund A/C) | 510,000 | 0.49% |
